Mohamed Elnaggar

Also affiliated with Hartford Hospital, Mansoura University, Hartford Financial Services (United States)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A

0Author DataRank · unranked

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Efficacy and Safety of Ileal Bile Acid Transport Inhibitors in Inherited Cholestatic Liver Disorders: A Meta-analysis of Randomized Controlled Trials”.

Efficacy and Safety of Ileal Bile Acid Transport Inhibitors in Inherited Cholestatic Liver Disorders: A Meta-analysis of Randomized Controlled Trials

Journal of Clinical and Experimental Hepatology(2025)10.1016/j.jceh.2024.102462

N/A

0.208DataRank · unranked

3 citations

Ahmed B. Elsnhory, Ahmed A. Ibrahim, Mohamed Elnaggar, Muhammad S. Tariq, Areeba M. Mehmood +6 more

The journey to LDL-C goal in the era of combination lipid lowering therapy and why it matters for ASCVD patients: a UK perspective

Current Medical Research and Opinion(2024)10.1080/03007995.2024.2400273

N/A

0.165DataRank · unranked

2 citations

Ashley M. Miller, Arunesh Sil, Adie Viljoen, Mohamed Elnaggar